License: CC BY-NC-SA 3.0 IGO
All content in this guide is provided strictly for scientific and educational purposes
Compound: CJC-1295 + Ipamorelin
As one FDA official put it: We dont actually know with any certainty what it is. Those doubts didnt convince the committee, which voted 86 to recommend that BPC-157 compounding be allowed
For those interested in conversion between different GLP-1 formulations , the general principle is to prioritize symptom management over dose equivalence
The dosage chart presented here provides a framework, but the clinical nuances, specifically the titration pace, the dose ceiling, the choice of synergistic agents, and the biomarker monitoring schedule, should be individualized by a physician familiar with both the patient's metabolic history and the evolving evidence base for mitochondrial peptide therapy